Immersive Technologies for Depression Care: Scoping Review
Open accessPublished version of a preprint
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 19 of the 41 sources its claims cite were checked for support.
Abstract
BACKGROUND: Depression significantly impacts quality of life, affecting approximately 280 million people worldwide. However, only 16.5% of those affected receive treatment, indicating a substantial treatment gap. Immersive technologies (IMTs) such as virtual reality (VR) and augmented reality offer new avenues for treating depression by creating immersive environments for therapeutic interventions. Despite their potential, significant gaps exist in the current evidence regarding the design, implementation, and use of IMTs for depression care. OBJECTIVE: We aim to map the available evidence on IMT interventions targeting depression treatment. METHODS: This scoping review followed a methodological framework, and we systematically searched databases for studies on IMTs and depression. The focus was on randomized clinical trials involving adults and using IMTs. The selection and charting process involved multiple reviewers to minimize bias. RESULTS: The search identified 16 peer-reviewed articles, predominantly from Europe (n=10, 63%), with a notable emphasis on Poland (n=9, 56%), which contributed to more than half of the articles. Most of the studies (9/16, 56%) were conducted between 2020 and 2021. Regarding participant demographics, of the 16 articles, 5 (31%) exclusively involved female participants, and 7 (44%) featured participants whose mean or median age was >60 years. Regarding technical aspects, all studies focused on VR, with most using stand-alone VR headsets (14/16, 88%), and interventions typically ranging from 2 to 8 weeks, predominantly in hospital settings (11/16, 69%). Only 2 (13%) of the 16 studies mentioned using a specific VR design framework in planning their interventions. The most frequently used therapeutic approach was Ericksonian psychotherapy, used in 56% (9/16) of the studies. Notably, none of the articles reported using an implementation framework or identified barriers and enablers to implementation. CONCLUSIONS: This scoping review highlights the growing interest in using IMTs, particularly VR, for depression treatment but emphasizes the need for more inclusive and comprehensive research. Future studies should explore varied therapeutic approaches and cost-effectiveness as well as the inclusion of augmented reality to fully realize the potential of IMTs in mental health care.
Overview
CoChat Summary
## TL;DR
This scoping review mapped 16 peer-reviewed articles (15 studies) on immersive technologies for depression care and found that all included interventions used virtual reality, not augmented reality. The evidence base was concentrated in Europe—especially Poland—and largely used stand-alone VR headsets and Ericksonian psychotherapy.
## Key findings
- The search identified 1052 records; after screening, 16 reports from 15 studies were included.
- All included studies used VR; 14/16 (88%) used stand-alone VR headsets, and none reported using augmented reality.
- Research was concentrated in Europe (10/16, 63%), with Poland contributing 9/16 (56%) of the reports.
- The most common therapeutic approach was Ericksonian psychotherapy (9/16, 56%); mindfulness-based cognitive therapy was used in 2/16 (13%), while cognitive behavioral therapy and behavioral activation were each used in 1/16 (6%).
- Most interventions lasted 2 to 8 weeks; the review also reports 11/16 (69%) were hospital based, and 14/16 (88%) did not clearly report the degree of guidance.
- Of the studies assessing depression outcomes, 14/16 (88%) assessed depressive symptoms; 1/16 (6%) reported no improvement, and 11/16 (73%) of the positive studies reported statistically significant results.
## Methods
- Scoping review following Arksey and O’Malley, expanded by Levac et al and Daudt et al, and reported using PRISMA-ScR 2020; protocol preregistered on Open Science Framework.
- Systematic search of MEDLINE (PubMed), Scopus, Web of Science, Embase, PsycINFO, IEEE Xplore, and Cochrane Library from database inception to October 10, 2023; limited to English-language articles.
- Included peer-reviewed randomized clinical trials in adults (≥18 years) where depression was a primary outcome and at least one group received immersive technology via head-mounted devices; data were synthesized narratively with frequencies and percentages.
## Limitations
- The paper states that screening by title/abstract and full text may have introduced selection bias if relevant studies were missed because of inadequate information in titles or abstracts.
- The search was limited to English-language articles, which the authors note could introduce language bias.
- Restricting inclusion to RCTs likely reduced comprehensiveness by excluding exploratory, observational, and qualitative studies; the review also notes it did not include a formal quality appraisal.
- Evident from the text: the evidence base was narrow in scope, with no AR studies, no implementation frameworks reported, and no barriers/enablers identified, limiting what can be concluded about implementation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
10 Valid · 1 Not valid · 17 Not checked · 38 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This trend denotes a divergence in the topics related to VR in health because most articles on VR in health, in general, have been published in the United States [50].”
§ Immersive Technologies for Depression Care: Scoping Review > Discussion > Secondary Questions
What the sources say
- Partly supportedcites [50] sourceExperimental — accuracy not yet measured
The Results, Annual Productivity section (page not supplied) identifies the United States as the leading country, with 94 of 356 articles (26.4%) published by researchers there. That supports the United States having the largest share, but not the claim that most articles were published there if “most” means a majority. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“and 1 (7%) did not perform any statistical analysis [41].”
§ Immersive Technologies for Depression Care: Scoping Review > Results > Overview
What the sources say
- Partly supportedcites [41] sourceExperimental — accuracy not yet measured
In Results > Clinical Efficacy (page unavailable), the paper says its sample was too small to conduct statistical analyses of clinical efficacy and presents the outcomes graphically. But Results > Pre- to Postactivity Mood Scores reports descriptive statistics, so the unqualified statement that it performed no statistical analysis is too broad. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“a systematic review concentrating on the mental health applications of AR did not reveal any applications of this particular IMT modality in either the treatment or the assessment of depression [53].”
§ Immersive Technologies for Depression Care: Scoping Review > Discussion > Secondary Questions
What the sources say
- Supportedcites [53] source
The Discussion (page unavailable) says the review found AR research in four domains—neurodevelopmental disorders, anxiety and phobia, psychoeducation and well-being, and procedural and pain management. Its summary of the 48 included studies does not identify depression treatment or assessment as an application. This supports the claim about what the review revealed, rather than a broader claim that no such applications exist. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“2 (13%) reported mixed results [40,42], indicating variability in statistical significance across different measures or outcomes”
§ Immersive Technologies for Depression Care: Scoping Review > Results > Overview
What the sources say
- Not checked yetcites [40] source
- Supportedcites [42] source
The citation identifies this trial as an example of a study with mixed results, rather than as the source of the citing paper’s count of 2 among 15 studies. The Results report significant improvements on some measures but no differences on others, including perceived effort and several between-group comparisons. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our results align with what has been previously observed in the literature, where it is noted that most articles published on VR in depression originate from Europe [51].”
§ Immersive Technologies for Depression Care: Scoping Review > Discussion > Secondary Questions
What the sources say
- Partly supportedcites [51] sourceExperimental — accuracy not yet measured
Section 3.5 (Publication by Countries; page not provided) says that most countries involved in VR research on anxiety and depression are European. It does not establish that most articles originate from Europe, and its analysis covers anxiety as well as depression. It also identifies the USA as the country with the most publications. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
38 more claims · 3 with their cited sources checked
Create a free account to see all 66 claims and to verify the 22 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, VR-assisted CR for depression is yet to be explored (24, 25).”
From A virtual reality-based self-guided training on identification of negative automatic thoughts in healthy adults: a mixed-methods feasibility study (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, no research has yet explored the potential of integrating NAT identification technique within VR for depression (25).”
From A virtual reality-based self-guided training on identification of negative automatic thoughts in healthy adults: a mixed-methods feasibility study (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Scoping studies: towards a methodological framework
Arksey, H., & O'Malley, L. (2005) · International Journal of Social Research Methodology · doi:10.1080/1364557032000119616 · Cited by 36,742 · cited 1×
“Our scoping review, conducted in accordance with the framework formulated by Arksey and O’Malley [26], identified a total of 16 peer-reviewed articles focusing on the use of IMTs in treating depression.”
MethodScoping studies: advancing the methodology
Levac, D., Colquhoun, H., & O'Brien, K. K. (2010) · Implementation Science · doi:10.1186/1748-5908-5-69 · Cited by 15,268
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
(2004) · JAMA · doi:10.1001/jama.291.21.2581 · Cited by 3,448 · cited 1×
“This shortage of resources highlights the urgent need for innovative solutions in mental health care [5].”
BackgroundJBI Manual for Evidence Synthesis
(2024) · doi:10.46658/jbimes-24-01 · Cited by 2,483
Daudt, H. M., van Mossel, C., & Scott, S. J. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-48 · Cited by 1,891
Torous, J., Bucci, S., Bell, I. H., Kessing, L. V., Faurholt‐Jepsen, M., Whelan, P., Carvalho, A. F., Keshavan, M., Linardon, J., & Firth, J. (2021) · World Psychiatry · doi:10.1002/wps.20883 · Cited by 1,199
Undertreatment of people with major depressive disorder in 21 countries
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L., Borges, G., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.188078 · Cited by 1,121 · cited 1×
“However, only 16.5% of people with depression worldwide receive treatment, indicating a substantial treatment gap [3].”
BackgroundInfluentialThe state of immersive technology research: A literature analysis
Suh, A., & Prophet, J. (2018) · Computers in Human Behavior · doi:10.1016/j.chb.2018.04.019 · Cited by 841 · cited 2×
“Inclusion and exclusion criteria (we defined immersive technologies as all augmented reality and virtual reality–only applications that belong to the degree of full immersion, according to the definitions provided in the literature [7,10]).”
Background
Research works printed but not linked: 2
- Ravitch, S, 2020, Qualitative Research Bridging the Conceptual, Theoretical, and Methodological
- Pocklington, C, 2017, Brit J Med Pract, 10, a1007
Cited by
Evaluating virtual reality technology in psychotherapy: impacts on anxiety, depression, and ADHD
Wang, P., Ai, X., Zhang, X. Q., Ma, F., Zhuang, Y., & Wang, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1480788 · Cited by 40
Smiley, A., & Finkelstein, J. (2024) · JMIR Biomedical Engineering · doi:10.2196/65734 · Cited by 9
Self-citationWilliamson, S. D., Aaby, A., & Ravn, S. L. (2025) · Spinal Cord · doi:10.1038/s41393-024-01057-7 · Cited by 10
Pu, Y., & Luo, H. (2025) · Discover Psychology · doi:10.1007/s44202-025-00384-x · Cited by 7
“For example, Reategui-Rivera et al. [33] reviewed 16 studies on immersive technology for depression, focusing exclusively on older and middle-aged adults.”
Advancing Mental Health with Immersive Virtual Reality: Benefits, Challenges, and Emerging Trends
Gkoumas, C., Bourikas, L., Mantadelis, T., & Karakasidou, E. (2024) · IEEE International Symposium on Mixed and Augmented Reality Adjunct (ISMAR-Adjunct) · doi:10.1109/ismar-adjunct64951.2024.00064 · Cited by 7
“Therefore, limited evidence makes it difficult to draw definitive conclusions about their overall efficacy [73, 30].”
Rocco, P., Reátegui-Rivera, C. M., & Finkelstein, J. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s526025 · Cited by 4
“35,36 Patient engagement in exercise programs can be facilitated by exergaming in virtual reality 37,38 and artificial intelligence-based chatbots 39,40 promoting patient education 41,42 and healthy behaviors.”
Self-citationCarta, M. G., Kurotschka, P. K., Machado, S. E. D. C., Erfurth, A., Sancassiani, F., Perra, A., Tusconi, M., Cossu, G., González, C. I. A., & Primavera, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164714 · Cited by 7
A systematic review on mindfulness-based immersive interventions in depressive disorders
Tan, P., Wu, Y., Chen, X., Chen, J., Guo, Z., Lu, X., Chen, J., & Zhang, H. (2026) · npj Mental Health Research · doi:10.1038/s44184-026-00205-6 · Cited by 3
“1) with MBIs — represent a potential solution 20 .”
Yang, B., Liao, C., Yang, Y., Shi, B., Zhang, C., & Li, C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1479207 · Cited by 2
“However, no research has yet explored the potential of integrating NAT identi fi cation technique within VR for depression (25).”
Regulation and applied science in psychotherapies
Bertolín-Guillén, J. M. (2024) · Psiquiatría Biológica · doi:10.1016/j.psiq.2024.100486 · Cited by 1
Current Applications of Artificial Intelligence in Psychiatry
Kerna, N. A., Boulos, A., Abreu, M., Chigozie, I. K., Fide-Nwoko, F. U., Arube, E. R., Eziechi, E. S., Holets, H. M., Pruitt, K. D., Jomsky, B. M., et al. (2025) · Scientia. Technology, science and society. · doi:10.59324/stss.2025.2(4).10 · Cited by 2
“Digital health platforms incorporating virtual reality (VR)–augmented CBT modules have shown promise in stress reduction and mindfulness enhancement, addressing unmet needs in accessibility and adherence (McIntyre et al., 2023; Reategui-Rivera et al., 2024).”
Shah-Mohammadi, F., & Finkelstein, J. (2024) · IEEE Annual Information Technology, Electronics and Mobile Communication Conference (IEMCON) · doi:10.1109/iemcon62851.2024.11093511 · Cited by 1
“The proposed methodology of clinical outcome terminology will facilitate the development of robust approaches supporting automated systematic meta-analysis of clinical trial results [27-28] as well as the conduct of scoping and narrative reviews [29-30].”
Self-citationImmersive technology applications in radiation protection for fluoroscopy - A systematic review
Videira, S., Rodrigues, M. A., Santos, J., & da Silva (2025) · Radiography · doi:10.1016/j.radi.2025.103179 · Cited by 2
Association between atherogenic index of plasma and depression risk: a meta-analysis
Chen, G., Chen, G.-X., & Wan, W. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1665118 · Cited by 1
Using Fitbit to Implement Personalized Walking Programs in Older Adults
Tsai, T.-Y., Smiley, A., & Finkelstein, J. (2024) · IEEE Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON) · doi:10.1109/uemcon62879.2024.10754777 · Cited by 1
“…utilizing real-world data from EHR [46-48], predictive analytics based on serial patient-reported outcomes [49-51], non-contact sensors [52-54], immersive virtual reality [55-57], and wearable devices [58-60] can greatly facilitate the impact of home-based telerehabilitation in the future.”
Self-citationCórdoba-Delgado, M. A., Sierra, V. M., López, J. G. R., Ferreira, N. S. M., Meza, M. G. C., & González-Ballesteros, L. M. (2026) · doi:10.2196/preprints.99756
Chen, S., Vermol, V. V., Yu, J., & Jiang, H. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1829947 · Cited by 1
Developing an Immersive Application of Therapeutic Art for Emotional Regulation
Hafiz, N. H. A., & Thani, A. F. A. (2026) · International Conference on e-Education, e-Business, e-Management and e-Learning · doi:10.1109/ic4e69618.2026.11631590
Ni, Y., Sun, Z., Li, Z., Piao, E., & Zhang, J. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1917295
“For example, VR environments can provide immersive scenarios where adolescents visualize their emotions or confront dif fi cult memories (65), while music acts as a tool to guide these processes.”
Metadata
- Authors
- Reategui-Rivera, C. M., Villarreal-Zegarra, D., De La Cruz-Torralva, K., Díaz-Sánchez, P., & Finkelstein, J.
- Affiliations
- National University of San Marcos (PE)
- University of Utah (US)
- ORCID
- Venue
- JMIR Mental Health
- Publisher
- JMIR Publications Inc.
- Published
- 2024-04-25
- Volume
- 11
- Pages
- e56056
- ISSN
- 2368-7959 (ISSN-L)
- PMC
- PMC11082738
- OpenAlex
- W4392890217
- Cited by
- 19
- References
- 63
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Mental Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- immersive technologies, depression treatment, virtual reality, augmented reality, Ericksonian psychotherapy, implementation barriers and facilitators, mental health services, treatment gap
- MeSH terms
- Depression, Humans, Virtual Reality Exposure Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

